Effectiveness and safety of ivermectin in the treatment of COVID-19: protocol for a systematic review and meta-analysis
Covid-19의 치료에서 Ivermectin의 효과 및 안전성 : 체계적인 검토 및 메타 분석을위한 프로토콜
Article
[키워드] acute respiratory syndrome
Admission
antiviral properties
antiviral property
approval
assessment
Bia
bias risk
carried
clinical
clinical pharmacology
clinical trial
clinical trials
Clinical use
COVID-19
criteria
database
development
Diagnosis
drug
Effectiveness
eligibility
Ethical approval
Ethics
Evidence
extracorporeal membrane oxygenation
for inclusion
Frequency
GRADE
hospitalisation
in some
incidence
include
Infection
Infectious diseases
intensive care
intensive care unit
Invasive mechanical ventilation
involved
item
Ivermectin
mean difference
Meta-analysis
methodology
Mortality
observational studies
observational study
outcome
outcomes
Patient
patients with COVID-19
PCR-negative
peer-reviewed
Placebo
Prophylactic
PROSPERO
protocol
public health
random-effects model
randomised clinical trial
Randomised clinical trials
Real-time PCR
registration number
registry
Relative risk
Reporting
required
respiratory
review
risk
serology test
Severe acute respiratory syndrome
Side effects
subgroup analysis
Support
Symptom
symptom resolution
Symptomatic treatment
systematic review
systematic reviews
the mean
Treatment
Trial
Viral
Viral load
[DOI] 10.1136/bmjopen-2021-050532 PMC 바로가기 [Article Type] Article
[DOI] 10.1136/bmjopen-2021-050532 PMC 바로가기 [Article Type] Article